$PMCB THERE IS WRITTEN: AT-THE-MARKET AGREEMENT FOR PHARMACYTE BIOTECH, INC. Represented PharmaCyte Biotech, Inc., a clinical-stage international biotechnology company providing cell and gene therapy solutions, in an “at the market” banking agreement with Chardan Capital Markets, LLC of up to $50 million.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.